Latest Eczema news
FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis
posted September 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Link Between n-3 LCPUFA, Eczema Varies by Maternal COX1 Genotype
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dietary Vitamin E May Be Protective Against Atopic Dermatitis
posted August 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With Eczema
posted August 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Risk for Herpes Zoster Elevated for Individuals With Atopic Dermatitis 
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis 
Review Shows Antihistamines Offer No Meaningful Benefit in Atopic Dermatitis Monthly Specialist Briefings
Stay Connected
